Increased serum level of IL-6 predicts poor prognosis in anti-MDA5-positive dermatomyositis with rapidly progressive interstitial lung disease
Arthritis Research & Therapy · 28.10.2024 · 26 (1)
DOI: 10.1186/s13075-024-03415-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arthritis Research & Therapy, online erschienen am 28.10.2024. Verfasst von Yuanyuan Niu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Practice, the First Affiliated Hospital of Sun Yat-sen University, No. 58 Zhongshan Er Road, Guangzhou, Guangdong Province, 510…. Hauptthemen laut MEDLINE: Dermatomyositis, Lung Diseases, Interstitial, Interferon-Induced Helicase, IFIH1, Interleukin-6. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUD: Anti-melanoma differentiation-associated protein 5 antibody-positive dermatomyositis (anti-MDA5-positvie DM) is a subtype of dermatomyositis with a poor prognosis, characterized by rapidly progressive interstitial lung disease (RP-ILD). The study aims to investigate the significance of serum cytokines profiles and peripheral lymphocytes in predicting prognoses of anti-MDA5-positvie DM with RP-ILD. Furthermore, it seeks to analyze longitudinal data of lymphocytes during hospitalization to identify distinct trajectories and cluster patients accordingly. METHODS: A total of 168 patients with anti-MDA5-positive DM were enrolled in this retrospective study from two cohorts. Univariate and multivariate Cox regression analyses were conducted to determine the predictors of 6-month all-cause mortality and RP-ILD. Group-based trajectory modeling (GBTM) was employed to model the trajectories of longitudinal peripheral lymphocytes. RESULTS: In the multivariate Cox regression analysis, IL-6 ≥ 13.41pg/mL, lymphocytes < 0.5 × 109 /L, lymphocytes from 0.5 to 1.0 × 109 /L, older age, and elevated LDH were identified as independent predictors of 6-month all-cause mortality. Furthermore, IL-6 ≥ 13.41pg/mL, lymphocytes < 0.5 × 109 /L, and lymphocytes from 0.5 to 1.0 × 109 /L were found to be independent predictors of RP-ILD. Additionally, three trajectory groups of lymphocytes within the first week after admission were established based on GBTM. These groups included: Group 1, with low-level of lymphocytes that declined; Group 2, with medium-level of lymphocytes that slightly rose; and Group 3, with high-level of lymphocytes that rose. Notably, group 1 showed the highest mortality (90.7%) and all experiencing RP-ILD. Increased expression of IL-6 in lung tissues was observed in two cases with RP-ILD compared to two cases without RP-ILD. We also found the increased infiltration of CD4 + and CD8 + T cells, particularly CD8 + T cells, in lung tissues from patients with RP-ILD. CONCLUSIONS: Our study demonstrated that increased level of serum IL-6 (≥ 13.41pg/mL) and severe lymphopenia were promising predictors of 6-month all-cause mortality and the occurrence of RP-ILD in anti-MDA5-positive DM patients. Furthermore, tracking distinct trajectories of lymphocytes during hospitalization can be utilized to cluster patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Practice, the First Affiliated Hospital of Sun Yat-sen University, No. 58 Zhongshan Er Road, Guangzhou, Guangdong Province, 510080, China.
- Department of Rheumatology and Immunology, the First Affiliated Hospital of Sun Yat-sen University, No. 58 Zhongshan Er Road, Guangzhou, Guangdong Province, 510080, China.
- Department of Rheumatology and Immunology, the First Affiliated Hospital of Guangzhou Medical University, No. 151 Yanjiang West Road, Guangzhou, Guangdong Province, 510120, China.
- Department of Rheumatology and Immunology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, No. 106 Zhongshan Er Road, Guangzhou, Guangdong Province, 510180, Ch…
- Department of Rheumatology and Immunology, the First Affiliated Hospital of Guangzhou Medical University, No. 151 Yanjiang West Road, Guangzhou, Guangdong Province, 510120, China. shanhui_ye@126.com.
- Department of Rheumatology and Immunology, the First Affiliated Hospital of Sun Yat-sen University, No. 58 Zhongshan Er Road, Guangzhou, Guangdong Province, 510080, China. xuhanshi@mail.sysu.edu.cn.
Zitieren
APA
Niu, Y., Liu, S., Qiu, Q., Fu, D., Xiao, Y., Liang, L., Cui, Y., Ye, S., & Xu, H. (2024). Increased serum level of IL-6 predicts poor prognosis in anti-MDA5-positive dermatomyositis with rapidly progressive interstitial lung disease. Arthritis Research & Therapy, 26(1). https://doi.org/10.1186/s13075-024-03415-5
Vancouver
Niu Y, Liu S, Qiu Q, Fu D, Xiao Y, Liang L, et al. Increased serum level of IL-6 predicts poor prognosis in anti-MDA5-positive dermatomyositis with rapidly progressive interstitial lung disease. Arthritis Research & Therapy. 2024;26(1). doi:10.1186/s13075-024-03415-5
BibTeX
@article{Niu2024,
author = {Niu, Yuanyuan and Liu, Suling and Qiu, Qian and Fu, Di and Xiao, Youjun and Liang, Liuqin and Cui, Yang and Ye, Shanhui and Xu, Hanshi},
title = {Increased serum level of IL-6 predicts poor prognosis in anti-MDA5-positive dermatomyositis with rapidly progressive interstitial lung disease},
journal = {Arthritis Research & Therapy},
year = {2024},
volume = {26},
number = {1},
doi = {10.1186/s13075-024-03415-5}
}
EUVIMED